by Artificial insemination is a medically assisted fertility procedure that involves inserting specially prepared sperm directly into a woman’s uterus or cervix to help her get pregnant. It provides an effective and affordable treatment option for couples experiencing fertility problems without needing in vitro fertilization. The increasing cases of infertility due to stress, changing lifestyle and late marriages has fueled the demand for artificial insemination as a means to start a family.
The global Artificial Insemination Market is estimated to be valued at US$ 9.2 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends
Increasing demand for assisted reproductive technology: The prevalence of infertility among couples is increasing worldwide due to changing lifestyle and hectic schedules that contribute to late pregnancies. Also, the rising awareness about the availability of artificial insemination as a cost-effective and less complicated treatment option than IVF is driving its adoption. Advanced artificial insemination techniques with improved success rates are further fueling the demand. Growing public funding for such procedures in several countries is also propelling the artificial insemination market growth.
SWOT Analysis
Strength: The artificial insemination market provides childless couples with an affordable option to conceive. Advances in AI techniques have improved pregnancy rates.
Weakness: The usage of donor sperm or eggs can raise ethical concerns. Success rates are still relatively low compared to natural conception.
Opportunity: Rising infertility rates due to changing lifestyles present a growing customer base. Adoption of AI in developing nations is yet to pick up.
Threats: Advent of newer assisted reproductive technologies like IVF poses competition. Social stigma around sperm/egg donation persists in some cultures.
Key Takeaways
The global artificial insemination market is expected to witness high growth. The global Artificial Insemination Market is estimated to be valued at US$ 9.2 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030.
Regional analysis shows that North America currently dominates due to established healthcare facilities and favorable reimbursement policies for fertility treatments. However, Asia Pacific is poised to be the fastest growing region due to the large patient pool and increasing medical tourism.
Key players operating in the artificial insemination market are Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd. These players are focusing on introducing innovative and affordable AI solutions. Strategic collaborations for expanding geographical presence have also been observed in the industry.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
